1818:HKEXBursa Malaysia Berhad Analysis
Data as of 2026-03-11 - not real-time
MYR 9.05
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Bursa Malaysia Berhad is trading at MYR 9.05, comfortably above its DCF‑derived fair value of MYR 4.61, indicating a sizable valuation premium. The stock sits above its 20‑day (8.99) and 50‑day (8.80) moving averages and also above the 200‑day level (8.16), signaling a bullish price trend despite a bearish MACD histogram. Momentum remains moderate with an RSI of 58.6 and volume trending upward, suggesting continued buying interest near the support zone at MYR 8.63. However, the forward PE of 24.8 and trailing PE of 29.2 far exceed the industry average of 17.3, reinforcing the view that the stock is currently overvalued. Fundamentals are robust – gross margin near 98%, operating margin 44.6%, and ROE close to 30% – and the balance sheet is strong with minimal debt and ample cash of MYR 576 million. The dividend yield of 3.13% looks attractive, but the payout ratio >100% raises concerns about sustainability. Low beta (0.20) and a 30‑day volatility of ~16% point to modest price swings, while increasing liquidity mitigates short‑term execution risk. Overall, the company’s stable cash flows and dominant market position underpin a positive outlook, but the pricing gap and dividend sustainability issues temper enthusiasm.
Investors should weigh the premium valuation against the solid earnings power and low systematic risk. In the near term, the stock may hover between its support and resistance levels, offering limited upside unless a price correction aligns market value with fundamentals. Over the longer horizon, a re‑rating toward fair value could unlock gains, provided the company manages dividend policy and maintains its high profitability.
Investors should weigh the premium valuation against the solid earnings power and low systematic risk. In the near term, the stock may hover between its support and resistance levels, offering limited upside unless a price correction aligns market value with fundamentals. Over the longer horizon, a re‑rating toward fair value could unlock gains, provided the company manages dividend policy and maintains its high profitability.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above short‑term moving averages indicating bullish trend
- Increasing trading volume supporting momentum
- Valuation premium relative to DCF and industry peers
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong profit margins and high ROE
- Elevated PE multiples suggesting limited upside
- Dividend payout ratio above 100% raising sustainability concerns
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Low beta and modest volatility imply defensive profile
- Robust cash generation and minimal debt provide financial flexibility
- Potential for valuation convergence toward fair value as market reassesses premium
Key Metrics & Analysis
Financial Health
Revenue Growth2.10%
Profit Margin34.58%
P/E Ratio29.2
ROE29.57%
ROA5.61%
Debt/Equity0.99
P/B Ratio9.2
Op. Cash FlowMYR243.7M
Free Cash FlowMYR208.0M
Industry P/E17.3
Technical Analysis
TrendBullish
RSI58.6
SupportMYR 8.63
ResistanceMYR 9.18
MA 20MYR 8.99
MA 50MYR 8.80
MA 200MYR 8.16
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91
Valuation
Fair ValueMYR 4.61
Target PriceMYR 9.06
Upside/Downside0.16%
GradeOvervalued
TypeValue
Dividend Yield3.13%
Risk Assessment
Beta0.20
Volatility16.04%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.